about
Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-betBarriers to preventive therapy for breast and other major cancers and strategies to improve uptakeSubcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implicationsLoss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.DNA methylation gene-based models indicating independent poor outcome in prostate cancer.Prevention and early detection of prostate cancer.Role of aspirin in cancer prevention.Estimates of benefits and harms of prophylactic use of aspirin in the general population.ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancerIndividualised benefit-harm balance of aspirin as primary prevention measure - a good proof-of-concept, but could have been better….Impact of preventive therapy on the risk of breast cancer among women with benign breast disease.Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population.Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK.Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.Revision surgery for breast cancer: single-institution experience.COX-2 expression does not correlate with microvessel density in breast cancer.Amplified in breast cancer 1 expression in breast cancer.Assessing opportunities for coordinated R&D in early cancer detection and management in Europe.Preventing invasive breast cancer using endocrine therapy.A major flaw in "Awareness of breast cancer and barriers to breast screening uptake in Bangladesh: A population based survey".Performance of the Xpert HPV assay in women attending for cervical screening.Tackling breast cancer in IndiaFOXA1 Expression in Breast Cancer Correlation with Luminal Subtype A and SurvivalRadiation therapy for ductal carcinoma in situ: is it really worth it?Developing countries: an evolving opportunity for oncologic researchMedical research in IndiaShould we undertake an MRI breast screening trial?Gene-signature-based prognostic tools in breast cancer: not yetWhat caused the decline in US breast cancer incidence?Does primary tumor location have prognostic significance in operable breast cancer?MRI breast screeningAre there distinct lymphatic flow patterns in the Breast?The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohortComment on "Dynamic response to heat--a novel physical characteristic of breast cancer"Sentinel lymph node assessment in breast cancer patients receiving neo-adjuvant chemotherapy: to biopsy before or after?Reply to the letter to the editor 'the harms of low-dose aspirin prophylaxis are overstated' by P. Elwood and G. Morgan
P50
Q24645449-2E18857B-0981-49E2-84CD-8198B7C31514Q26774593-9234E11C-9778-46CD-B265-9F3CB0D39E49Q33816285-2FFAF809-A81D-40B4-93B9-30C3BA31451AQ34167687-9DD331D4-CD7D-4DAE-B720-32D57BB2CC66Q34174356-45E10FF9-6DFC-457A-8671-638354322776Q34371057-13D939F2-FF5E-40CE-AE9F-02B7CD5AEE35Q34376832-ECE4E689-4724-4E61-9F32-B4FE9490C3B3Q34432503-1B9ED445-540F-44CE-A43F-8FE5762C1B88Q34582136-F8512AB2-4E20-46E7-A99F-9930B1C3F82EQ36068944-3E8371E7-0819-4C68-9E73-06962E5609DEQ36258270-75F38512-0BFF-49ED-A747-356178BACFC3Q36609819-213F9910-9C93-479C-81D6-68BB2DB6AD5BQ38271121-5A049171-FFEF-4166-92C9-8F172B496375Q41925248-9A46033B-6796-4150-BFB5-52F3155BBB81Q42043154-23677A93-8DDF-408E-8C91-BF94D5843659Q42462949-CDAA3D57-30A1-4B0F-84F1-506C4D578605Q42521804-B5A63449-9DAD-4133-A584-D5B46ACCD5A9Q43234010-F7696B41-5F70-4D9A-AD26-AA2E2CBCA331Q43644347-7E375CE7-C3BC-4E27-990C-81566EA4BE0FQ44048234-5B7F2087-9BFE-40CA-892F-FC45B9E109FBQ46186654-4DAED2D2-58AA-4638-97F2-2C315E4B1711Q50470347-00DDDDA3-EE58-40CB-B224-A3F7BA1824C7Q51843372-54564BBC-C4A7-4F64-A8CE-3FC6F1890047Q54477214-F67031DB-4D31-49A0-8FDF-A0CF089282D1Q55259586-404A1CD5-5996-4624-AA7C-971699456C13Q56659600-70943BB9-695E-4601-98D1-6C91E45492D1Q59565516-3CE925AA-F122-4D2B-827E-7240A6BA3815Q79691866-F098E6C9-50DF-403C-B75B-4DE5B22C0950Q79776439-B8312CDC-9D58-49FD-B9B3-2E750BFF8EFCQ80141284-1293BA39-58EB-485A-B0FA-C68EABA5FE3FQ80168591-98D7C2FB-F5AC-408A-BDE0-519D6D5EE34BQ80235048-7FA78C93-A974-4E09-B13D-1726A28BF43CQ81090355-BFA61E8E-6360-4F3C-8ABA-B47A826E791AQ81136409-BFD9D7FA-3368-4A8A-A8B8-4AA688152183Q81161996-69711D42-F0CA-4A0E-B448-60A41232ABD2Q82419872-A7802AB4-0953-4D0F-947A-1DFE3BC4A55AQ83091557-6759BDB3-662F-46B6-950B-02A332315E71Q83269244-6A564D6F-5379-4AA6-8106-3F0EADCAD3D8Q85673043-2A7947D7-8D63-4B73-8ED2-0CE611B94D85Q86001732-938402A4-268B-41A3-A010-DBB9049B11BC
P50
description
researcher, ORCID id # 0000-0001-8673-5320
@en
wetenschapper
@nl
name
Mangesh Thorat
@ast
Mangesh Thorat
@en
Mangesh Thorat
@es
Mangesh Thorat
@nl
type
label
Mangesh Thorat
@ast
Mangesh Thorat
@en
Mangesh Thorat
@es
Mangesh Thorat
@nl
prefLabel
Mangesh Thorat
@ast
Mangesh Thorat
@en
Mangesh Thorat
@es
Mangesh Thorat
@nl
P214
P244
P106
P1153
10439116700
P214
P244
nb2014007191
P31
P496
0000-0001-8673-5320
P7859
lccn-nb2014007191